Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients

NCT04610502 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER_GOV

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: Administration of Equine immunoglobulin anti SARS-CoV-2

Sponsor

Caja Costarricense de Seguro Social

Collaborators

[object Object]
[object Object]